Malignant ovarian germ-cell tumours.
Malignant ovarian germ-cell tumours account for about 5% of all ovarian malignancies and typically present in the teenage years. They are almost always unilateral and are exquisitely chemosensitive. As such, the surgical approach in young women with such tumours confined to a single ovary should aim to preserve fertility. In early disease, a unilateral salpingo-oophorectomy with careful surgical staging is of great importance in selecting appropriate adjuvant therapy. In advanced disease, the role of aggressive cytoreducation is not well defined, and removal of both ovaries does not confer improvement in outcome. Bleomycin, etoposide and cisplatin combination chemotherapy is regarded as the gold standard for adjuvant therapy. Studies evaluating ovarian and reproductive capacity after conservative surgery and chemotherapy for malignant ovarian germ-cell tumours have consistently demonstrated excellent prognosis, with the return of normal menstrual function and fertility rates in these women with no increase in the risk of teratogenicity.
Division of Gynaecologic Oncology, Department of Obstetrics and Gynaecology National University Hospital, NUHS Tower Block, Singapore, Singapore. Jeffrey_Low@nuhs.edu.sg
Jeffrey J H
JJ
Low
Arunachalam
A
Ilancheran
Joseph S
JS
Ng
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects; D005260:Female; D059247:Fertility Preservation; D006801:Humans; D007247:Infertility, Female / Q000517:prevention & control; D009367:Neoplasm Staging; D009373:Neoplasms, Germ Cell and Embryonal / Q000473:pathology* / Q000628:therapy*; D059351:Organ Sparing Treatments; D010051:Ovarian Neoplasms / Q000473:pathology* / Q000628:therapy*; D010052:Ovariectomy; D010053:Ovary / Q000187:drug effects / Q000503:physiopathology; D058994:Salpingectomy